ABVC BioPharma, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net
ABVC BioPharma, Inc. (ABVC) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of $243.39 thousand as of 2023-12-31, per its 10-K filed 2024-03-13.
Financial Statements › Notes › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet · last filed 2025-04-15
- 2023-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $243.39K.
- 2023-12-15: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net -$243.39K.
- 2019-02-08: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $694.22K.
- 2018-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $810.40K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net |
|---|---|
| 2023-12-31 | $243.39K 10-K · filed 2024-03-13 |
| 2023-12-15 | -$243.39K 10-K · filed 2025-04-15 |
| 2019-02-08 | $694.22K 10-Q · filed 2022-11-14 |
| 2018-12-31 | $810.40K 10-K · filed 2019-04-15 |